Lucid Diagnostics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 792.00 shares, a 91.20% decline year-over-year.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 15.16K shares, a 700.69% increase year-over-year.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 1.52K shares.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 2.12K shares.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 14.53K shares, a 335.94% increase from fiscal 2024.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 3.33K shares.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 965.34K shares.
- Lucid Diagnostics Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 4.70K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 792.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 19.59K shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 15.16K shares 10-Q · filed 2026-05-13 | 27.79K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 1.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 14.53K shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 2.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 13.01K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-06-30 | 9.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 10.89K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2025-03-31 | 1.89K shares 10-Q · filed 2025-05-13 | 1.89K shares derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | 3.33K shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | |
| 2024-03-31 | 3.33K shares 10-Q · filed 2024-05-13 | |
| 2022-12-31 | 965.34K shares 10-K · filed 2024-03-25 | |
| 2022-06-30 | 705.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | |
| 2022-03-31 | 253.89K shares 10-Q · filed 2022-05-16 | |
| 2020-12-31 | 4.70K shares 10-K · filed 2022-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |